MIRA INFORM REPORT

 

 

Report Date :

21st June, 2006.

 

IDENTIFICATION DETAILS

 

Name :

SHIWA CHEMICALS COMPANY LIMITED

 

 

Registered Office :

34/1  Soi  Prompong,  Sukhumvit  39  Road, Klongtonnua,  Wattana,  Bangkok  10110

 

 

Country :

Thailand

 

 

Financials (as on) :

31.12.2004

 

 

Date of Incorporation :

1962

 

 

Com. Reg. No.:

0105505002268  [Former: 337/2505]

 

 

Legal Form :

Private Limited  Company

 

 

Line of Business :

The subject is engaged in distributing a broad range of local and international brands of pharmaceuticals

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

sStatus :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 


 

Company Name

 

SHIWA  CHEMICALS  CO.,  LTD.

 

 

SUMMARY

 

BUSINESS  ADDRESS                          :           34/1  SOI  PROMPONG,  SUKHUMVIT  39  ROAD,

                                                                        KLONGTONNUA,  WATTANA,  BANGKOK  10110

TELEPHONE                                         :           [66]  2258-0586-9

FAX                                                      :           [66]  2258-3795

E-MAIL  ADDRESS                                :           contact@shiwa.co.th

REGISTRATION  ADDRESS                  :           SAME  AS  BUSINESS  ADDRESS

ESTABLISHED                                     :           1962

REGISTRATION  NO.                           :           0105505002268  [Former: 337/2505]

CAPITAL REGISTERED                         :           BHT.  10,000,000

CAPITAL PAID-UP                                :           BHT.  10,000,000

FISCAL YEAR CLOSING DATE              :           DECEMBER   31            

LEGAL  STATUS                                  :           PRIVATE  LIMITED  COMPANY

EXECUTIVE                                          :           MRS.  SUPUNNEE  RATTAKUL,  THAI

                                                                        MANAGING  DIRECTOR           

NO.  OF  STAFF                                   :           25

LINES  OF  BUSINESS                          :           PHARMACEUTICALS

                                                                        IMPORTER  AND  DISTRIBUTOR

                                                                         

                                                                         

 

CORPORATE  PROFILE

 

OPERATING  TREND                            :           STABLE                       

PRESENT  SITUATION                          :           OPERATING  NORMALLY                     

REPUTATION                                       :           GOOD  WITH  NORMAL  BUSINESS  ENGAGEMENT

MANAGEMENT  STANDARD                 :           MANAGEMENT  WITH  FAIR  PERFORMANCE             

 

 

 

HISTORY

 

The  subject  was  established  on   December  25,  1962   as  a  private  limited  company under  the  original   name  style  New  Ruamsahai  Co.,  Ltd.”,    by  Thai  groups.  On  March  10,  1969, the  subject  was  changed  its  name  to  be  SHIWA  CHEMICALS  CO.,  LTD.  Its  business  objective  is  a  distributor  broad  range  of  local  and  international  brands  of  pharmaceuticals   to  domestic  market.  It  currently  employs  approximately  25  staff.  

 

The  subject’s  registered  address  is  34/1  Sukhumvit  39  Rd.,  Klongtonnua,  Wattana,  Bangkok  10110,   and  this  is  the  subject’s  current  operation  address.  

 


 

THE  BOARD  OF  DIRECTORS

 

     Name

 

Nationality

Age

 

 

 

 

Mrs. Supunnee  Rattakul

 

Thai

55

Mr. Saendee  Rattakul

 

Thai

52

Mr. Supassorn  Rattakul

 

Thai

31

Mrs. Peng  Eiamsakulrat

 

Thai

70

 

AUTHORIZED  PERSON

 

One  of  the   above  directors  can  sign  on  behalf  of  the  subject  with  company’s  affixed.

 

 

MANAGEMENT

 

Mrs. Supunnee  Rattakul  is  the  Managing  Director.

She  is  Thai  nationality  with  the  age  of   55  years  old.

 

Mr. Sombat  Hataipeamsuk  is  the  Sales  Manager.

He  is  Thai  nationality. 

 

 

BUSINESS  OPERATIONS

 

The  subject  is  engaged   in  distributing  a  broad  range  of  local  and  international  brands  of  pharmaceuticals,  which can  be  divided  into  4  business  groups  as  follows:

 

·         Pharmaceuticals  and  systems

·         Nutraceuticals   and  Cosmaceuticals

·         Hygiene  and  Specialty  products

·         Culinary  applications

 

 

PURCHASE

 

80%  of  the  products  is  imported  from  France,  United  Kingdom,  Germany  &  Sweden,  the  remaining  20%  is  purchased  locally.

 

 

SALES 

 

100%  of  the  products  is  sold  locally  by  wholesale  to  dealers  and  end-users,  mainly  hospitals,  clinics  and  drug  stores.

 

 

REVENUE

 

In  2005,  the  subject’s  revenue  was  increased  around  20%  from  the  previous  year.

 

 

SUBSIDIARY  AND  AFFILIATED  COMPANY

 

The  subject  is  not  found   to  have  any  subsidiary  nor  affiliated  company  here  in  Thailand.

 

 

LITIGATION

 

Bankruptcy  and  Receivership

 

There  are  no  litigation  on  bankruptcy  and  receivership  cases  filed  against  the  subject  found  at  Legal  Execution  Department  for  the  past  five  years.

 

Others

 

There  are  no  legal  suits  filed  against   the  subject  for  the  past  two  years.

 

CREDIT  

 

Sales  are  by  cash  or  on  the  credits  term  of  30-60  days. Local  bills  are  paid  by  cash  or  on  the  credits  term  of  30-60  days. Imports  are  by  L/C  at  sight  or  T/T.

 

 

BANKING

 

Bangkok  Bank  Public  Co.,  Ltd.

Kasikornbank  Public  Co.,  Ltd.

The  Siam  Commercial  Bank  Public  Co.,  Ltd.

 

 

EMPLOYMENT

 

The  subject  employs  approximately  25   staff  

 

 

LOCATION   DETAILS

 

The  premise  is  rented  for  administrative  office  at  the  heading  address.  Premise  is  located  in  commercial/ residential  area.

 


 

COMMENT

 

Since the subject was established in 1962,  its products have been  promoted and well accepted from local market.

 

The  market of  pharmaceuticals  has  grown impressively  because  of  growing  of  healthcare

industry.

 

 

FINANCIAL  INFORMATION

 

The  capital  was  registered  at  Bht.  1,000,000  divided  into  10,000   shares  of  Bht.    100   each.

 

The  capital  was  increased  later  as  following:

 

Bht.      4,000,000  on    April  1,  1974

Bht.    10,000,000  on     August  7,  1984

           

The  latest  registered  capital  was  increased  to  Bht. 10,000,000  divided  into  100,000   shares  of  Bht.  100   each  with  fully  paid.

 

 

THE  SHAREHOLDERS  LISTED  WERE  :  [as  at   April  30,  2005 ]

 

       NAME

HOLDING

%

 

 

 

Mrs. Supunnee  Rattakul

Nationality:  Thai

Address    :  34  Sukhumvit  39  Rd.,  Klongtonnua, 

                   Wattana,  Bangkok

54,500

54.50

Mr. Saendee  Rattakul

Nationality:  Thai

Address    :   34  Sukhumvit  39  Rd.,  Klongtonnua, 

                    Wattana,  Bangkok

20,000

20.00

Mrs. Peng  Eiamsakulrat

Nationality:  Thai

Address    :  34  Sukhumvit  39  Rd.,  Klongtonnua, 

                   Wattana,  Bangkok

10,000

10.00

Mrs. Ladda  Mudjanathongsuk

Nationality:  Thai

Address    :  15/6  Klongtonnua,  Wattana,  Bangkok

5,000

5.00

Mr. Supassorn  Rattakul

Nationality:  Thai

Address    :  34  Sukhumvit  39  Rd.,  Klongtonnua, 

                   Wattana,  Bangkok

5,000

5.00

Ms. Duangporn  Mudjanathongsuk

Nationality:  Thai

Address    :  15/6  Klongtonnua,  Wattana,  Bangkok

5,000

5.00

 


 

Ms. Chanida  Mudjanathongsuk

Nationality:  Thai

Address    :  15/6  Klongtonnua,  Wattana,  Bangkok

500

0.50

 

Total  Shareholders  :    7

 

 

NAME  OF  AUDITOR  &  CERTIFIED  PUBLIC   ACCOUNTANT  NO. :

 

Mrs. Traporn  Thawanwong         No.  2860

 

 

SHIWA  CHEMICALS  CO., LTD.

 

 

BALANCE SHEET [BAHT]

 

 

 

The  latest  financial  figures  published  for  December  31,  2004  &  2003  were:

          

ASSETS

 

                                                                                               

Current Assets

2004

2003

 

 

 

Cash   in   hand  &  at  Bank             

666,672.40

2,475,529.54

Short  Term  Investment

1,001,460.60

1,001,455.13

Trade  Accts.  Receivable

8,399,110.12

9,866,040.91

Inventories                      

4,702,040.73

4,639,692.93

Other  Current  Assets               [note 1]  

565,611.00

480,345.49

 

Total  Current  Assets                

 

15,334,894.85

 

18,463,064.00

 

 

 

Fixed Assets                             [note 3]

1,131,097.37

1,234,446.14

Other Assets                             [note 2]

359,152.85

411,507.63

 

Total  Assets                 

 

16,825,145.07

 

20,109,017.74


 

 

LIABILITIES & SHAREHOLDERS' EQUITY [BAHT]

 

 

Current Liabilities

2004

2003

 

 

 

Trade  Accts.  Payable

3,442,199.54

4,742,799.00

Other  Current  Liabilities             

414,872.51

398,270.33

 

Total Current Liabilities

 

3,857,072.05

 

5,141,069.33

 

Long  Term  Loan  from  Related  Person

 

7,200,000.00

 

7,700,000.00

Other  Long  Term Loan

8,000,000.00

8,000,000.00

 

Total  Liabilities            

 

19,057,072.05

 

20,841,069.33

 

 

 

Shareholders' Equity

 

 

 

 

 

 Share  capital : Baht  100  par  value 

  authorized,  issued  and  fully 

  paid  share  capital   100,000  shares

 

 

10,000,000.00

 

 

10,000,000.00

 

Capital  Paid                      

 

10,000,000.00

 

10,000,000.00

Retained  Earning - Unappropriated                

 [12,231,926.98]

[10,732,051.59]

 

Total Shareholders' Equity

 

[2,231,926.98]

 

[732,051.59]

 

Total Liabilities  &  Shareholders'  Equity

 

16,825,145.07

 

20,109,017.74

 


                                                  

PROFIT  &  LOSS  ACCOUNT

 

 

Revenue

2004

2003

 

 

 

Sales                                         

22,831,335.04

31,575,460.07

Other  Income                 

225.77

857.50

Interest  Income

4,924.67

10,862.24

 

Total  Revenues           

 

22,836,482.48

 

31,587,179.81

 

Expenses

 

 

 

 

 

Cost   of   Goods   Sold                           

9,299,715.10

14,010,428.49

Selling  &  Administrative  Expenses

14,256,642.77

17,539,206.89

 

Total Expenses             

 

23,556,357.87

 

31,549,635.38

 

Profit / [Loss]  Before  Interest  Expenses

 

[719,875.39]

 

37,544.43

Interest  Expenses

[780,000.00]

[825,000.00]

 

Net  Profit / [Loss]

 

[1,499,875.39]

 

[787,455.57]

 

 

FINANCIAL  NOTE

 

NOTE  1  Other  Current  Assets

 

 

2004

2003

 

 

 

Deferred  Income

178.08

328.80

Receivable-Revenue  Department

-

49,422.52

Prepaid  Expenses

119,619.04

86,943.47

Guarantee

270,323.00

80,920.00

Advanced  Paid

51,232.00

105,472.00

Withholding  Income  Tax

124,258.88

157,258.70

 

   Total    

 

565,611.00

 

480,345.49

 

NOTE 2  Other  Assets

 

 

2004

2003

 

 

 

Deposit

38,800.00

38,800.00

Withholding  Income  Tax

320,852.85

372,707.63

 

   Total    

 

359,652.85

 

411,507.63

 


 

NOTE  3  Fixed  Assets

 

 

2004

 

 

Improvement

80,390.81

Office  Automation

2,827,559.50

Vehicle

4,195,552.06

  Total

7,103,502.37

  Less:  Depreciation

[5,972,405.00]

 

   Total    

 

1,131,097.37

 

 

SHIWA  CHEMICALS  CO., LTD.

 

FINANCIAL  ANALYSIS

 

Annual  Growth  &  Profitability   

 

 

Annual  Growth

 

2004

 

2003

 

Sales

 

[27.69]

 

 

 

Operating

 

[3.27]

 

 

 

Net  Profit

 

[90.47]

 

 

 

Fixed  Assets

 

[8.37]

 

 

 

Total  Assets

 

[16.33]

 

 

 

Profitability

 

 

 

 

 

Cost  of  Goods  Sold

 

40.73

 

44.37

 

Operating  Profit  Margin

 

59.27

 

55.63

 

S&A  expenses

 

62.44

 

55.55

 

Interest

 

3.42

 

2.61

 

Other  Revenues

 

0.02

 

0.04

 

Net  Profit  Margin

 

[6.57]

 

[2.49]

 

Earning  Per  Shares

 

[15.00]

 

[7.87]

 

No.  of  Shares

 

100,000

 

100,000

 

Net  Sales  was  decreased  by  27.69%,  Operating  Profit  was  decreased  by  3.27%,  Net  Profit  was  decreased  by  90.47%,  Fixed  Assets  was  decreased  by  8.37%,  Total  Assets  was  decreased  by  16.33%.

 

 

 

 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Compare  each  cost  with  sales,  Cost  of  Goods  Sold  was  decreased  from  44.37%  to  40.73%,  Operating  Profit  Margin  was  increased  from  55.63%  to  59.27%,  S  &  A  Expenses  were  increased  from  55.55%  to  62.44%,  Interest  Paid  was  increased  from  2.61%  to  3.42%,  Other  Revenues  was  decreased  from  0.04%  to  0.02%,  Net  Profit  Margin  was  decreased  from  -2.49%  to -6.57%.

 

Earning  Per  Shares  was  decreased  from  -7.87  baht  per  share  to -15.00  baht  per  share.

 

 


 

Liquidity

 

 

 

Liquidity

 

2004

 

2003

 

Current  Ratio

 

3.98

 

3.59

 

Quick - assets  ratio

 

2.61

 

2.60

 

 

Current  Ratio  was  increased  from  3.59  to  3.98,  show  Current  Assets  can  cover  Current  Liabilities,  Liquidity  Ratio  of  the  company  was  good,  and  Quick-assets  Ratio  was  increased  from  2.60  to  2.61,  capacity  to  pay  Short  Term  Loan  was  good  too,  because  Current  Assets  without  Inventory  can  cover  Current  Liabilities.

 

 

 

 


Leverage

 

 

Leverage

 

2004

 

2003

 

D/E  Ratio

 

[8.54]

 

[28.47]

 

Times  Interest  Earned

 

[0.93]

 

0.03

 

 

D/E  Ratio  was  increased  from  -28.47  to  -8.54,  show  the  company  had  fund  from  Loan  more  than  fund  from  Equity,  investment  risked  of  the  company  is  high  and  Times  Interest  Earned  was  decreased  from  0.03  to  -0.93,  capacity  to  pay  interest  paid  was  not  good.

 

 

 

 

 

 

 

 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 


Efficiency

 

 

Efficiency

 

2004

 

2003

 

Fixed  Assets  Turnover

 

20.19

 

25.58

 

Total  Assets  Turnover

 

1.36

 

1.57

 

Return  on  Assets

 

[8.91]

 

[3.92]

 

Return  on  Equity

 

[67.20]

 

[107.57]

 

Day’s  Payable

 

135.10

 

123.56

 

Day’s  Inventories

 

184.55

 

120.87

 

Days’  Receivables

 

134.27

 

114.05

 

Fixed  Assets  Turnover  was  decreased  from  25.58  times  to  20.19  times,  Total  Assets  Turnover  was  decreased  from  1.57  times  to  1.36  times,  show  the  company  could  not  use  Assets  so  efficiently,  and  Return  on  Assets  was  decreased  from  -3.92  to  -8.91,  Return  on  Equity  was  increased  from  -107.57  to  -67.20,  capacity  to  use  Assets  to  make  profit  was  not  good.

 

Day’s  Payable  was  increased  from  124  days  to  136  days,  Day’s  Inventories  was  increased  from  121  days  to  185  days,  and  Day’s  Receivables  was  increased  from  115  days  to  135  days.

 

 
 

 


 


RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions